-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Aridis Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2017 to Q3 2023.
- Aridis Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$869K, a 88.3% increase year-over-year.
- Aridis Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$883K, a 97.2% increase year-over-year.
- Aridis Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$30M, a 29.8% increase from 2021.
- Aridis Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$42.7M, a 90.7% decline from 2020.
- Aridis Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$22.4M, a 23% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)